Minutia

Minutia is a next-generation cell therapy company focused on developing a groundbreaking approach to diabetes treatment by transplanting insulin-producing cells with nanosensors. Their innovative technology aims to create more robust and controlled insulin-producing cell transplants that can be monitored in vivo, potentially revolutionizing diabete... s and cell replacement therapy. With a strong emphasis on research and development, Minutia has received grants from institutions like the National Institutes of Health and the California Institute for Regenerative Medicine. The company's work has been recognized by prestigious organizations and featured in various publications, solidifying its position as a leader in the field.Read More